- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03396055
Investigation in Integrated Perspective of Radiculomyelopathy Patients
Investigation of the Relationship Between Surgical Approaches, Psychological Intervention, Neuromuscular Control, Rehabilitation Exercise and Biomechanical Characteristics in Radiculomyelopathy Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Neck pain, which is common in population recently, is causing the huge burden in the global medical service system. Cervical myelopathy, that is induced by disc degeneration, is turning to be an alarming public health issue. The clinical manifestations of cervical myelopathy include neck/shoulder pain, numbness/weakness of four limbs, sensorimotor impairment, and sociopsychological dysfunction. However, most of the previous studies tend to justify patients, prognosis in a single dimension. The investigators realized that no standard protocol for management in patients with the variety of manifestation and severity of signs and symptoms.This study is purposed to integrate and analyze the finding in surgery selection, clinical manifestation, psychological consultation, compensatory patterns in the neuromusculoskeletal system, postural control, home exercise and biomechanical features. Then, the investigators will develop a complementary model in assessment and prediction of prognosis, and also an applicable standard guideline in the clinical setting. To achieve the expected target, the principal investigator will play the role as the main coordinator in the team. The 3-year plan is listed as below:
- In the first year, the patients will be recruited for projects from different co-investigators. The recruited participants will be allocated to different study group after assessment to ensure the most suitable intervention are offered to the participants.
- In the second year, the participants' recruitment will be continuing. The effectiveness previous treatment will be assessed. The study procedure will be adjusted based on pilot results.
2. In the third year, the study finding of all co-investigators and results of the biomechanical analysis will be integrated to establish the model of prognosis prediction and clinical management guideline. This study will provide a complete clinical management guideline in cervical myelopathy, which is expected to be globally leading reference in the management of cervical myelopathy.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Taipei, Taiwan, 100
- National Taiwan University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosed as cervical myelopathy or radiculopathy based on imaging results
Exclusion Criteria:
- With spondylolisthesis, rheumatoid arthritis, multiple sclerosis
- With cancer/tumor
- With neurological or psychological disorder
- Not suitable for cervical decompression surgery or physical therapy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
NO_INTERVENTION: Control
No intervention
|
|
|
EXPERIMENTAL: Treatment group
Specific rehabilitation exercise
|
specific rehabilitation exercise for patients with cervical myelopathy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neck Disability Index (NDI)
Time Frame: 1 year
|
Questionnaire
|
1 year
|
|
Japanese Orthopaedic Association Myelopathy Evaluation Questionnaire (JOACMEQ)
Time Frame: 1 year
|
Questionnaire
|
1 year
|
|
Modified Japanese Orthopaedic Association Scale (Modified JOA scale)
Time Frame: 1 year
|
Investigator-administered scale Sub-scale 1: Motor Dysfunction score of the upper extremity (maximum score-5, minimum score-0) Sub-scale 2: Motor Dysfunction score of the lower extremity (maximum score-7, minimum score-0) Sub-scale 3: Sensory dysfunction score of the upper extremities (maximum score-3, minimum score-0) Sub-scale 4: Sphincter dysfunction (maximum score-3, minimum score-0) Higher score shows better outcome
|
1 year
|
|
Nurick scale
Time Frame: 1 year
|
Investigator-administered scale The total maximum score is 5: the total minimum score is 0. Higher score shows worse outcome
|
1 year
|
|
Grip and release test
Time Frame: 1 year
|
Functional movement
|
1 year
|
|
Foot taping test
Time Frame: 1 year
|
Functional movement
|
1 year
|
|
5 times sit to stand
Time Frame: 1 year
|
Functional movement
|
1 year
|
|
10 second step test
Time Frame: 1 year
|
Functional movement
|
1 year
|
|
Kinetic variables
Time Frame: 1 year
|
The ground reaction force, moment and center of pressure recorded by force platform during standing and ambulation.
|
1 year
|
|
Neuropathic Pain Symptom Inventory
Time Frame: 1 year
|
Questionaire
|
1 year
|
|
Magnetic Resonance Imaging (MRI)
Time Frame: 1 year
|
The cortical network of patients assessed by Diffusion Spectrum Imaging of the brain
|
1 year
|
|
SF-36
Time Frame: 1 year
|
Questionnaire
|
1 year
|
|
WHOQOL_BREF
Time Frame: 1 year
|
Questionnaire
|
1 year
|
|
Kinematic variables
Time Frame: 1 year
|
Range of motion
|
1 year
|
|
Muscle activities in Electromyography (EMG)
Time Frame: I year
|
Muscle activities in neck and lower limbs
|
I year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Dar-Ming Lai, Ph.D, National Taiwan Unversity Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201505093RINA
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.